Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$186.39M
Total Bought:
$14.26M
Total Sold:
$8.81M
Net Transaction:
+$5.45M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Aclaris Therapeutics, Inc.(ACRS)11,975,00010,955,000-1,020,000$63.35M$57.62M30.92%-$5.72M
Atea Pharmaceuticals, Inc.(AVIR)6,952,3306,753,658-198,672$32.33M$35.19M18.88%+$2.86M
enGene Therapeutics Inc.(ENGN)6,669,9086,669,9080$11.54M$13.34M7.16%+$1.80M
PMV Pharmaceuticals, Inc.(PMVP)5,330,0007,330,000+2,000,000$7.14M$12.24M6.57%+$5.10M
The Kraft Heinz Company(KHC)465,000475,000+10,000$10.98M$10.79M5.79%-$191.3K
Tilly's, Inc.CL A(TLYS)2,150,0002,150,0000$9.03M$9.95M5.34%+$924.5K
CarMax, Inc.(KMX)172,500172,5000$9.12M$9.51M5.10%+$382.9K
Outset Medical, Inc.(OM)2,519,7012,519,7010$10.89M$7.56M4.06%-$3.33M
Target Corporation(TGT)37,50037,5000$4.90M$5.88M3.15%+$978.0K
Seer, Inc.CL A(SEER)02,186,587+2,186,587$0$4.88M2.62%+$4.88M
Instil Bio, Inc.(TIL)645,600645,6000$4.96M$4.67M2.51%-$290.5K
Connect Biopharma Holdings LimitedSHS(CNTB)573,2873,864,400+3,291,113$1.36M$4.25M2.28%+$2.89M
Oramed Pharmaceuticals Inc.(ORMP)866,269884,392+18,123$4.17M$4.13M2.22%-$36.6K
Janux Therapeutics, Inc.(JANX)154,961151,126-3,835$2.38M$2.61M1.40%+$231.3K
Pliant Therapeutics, Inc.(PLRX)1,546,1371,546,1370$1.76M$1.67M0.90%-$92.8K
LENZ Therapeutics, Inc.(LENZ)0283,114+283,114$0$1.09M0.58%+$1.09M
ImageneBio, Inc.(IMA)200,730200,7300$1.18M$919.3K0.49%-$265.0K
Karyopharm Therapeutics Inc.(KPTI)071,839+71,839$0$87.6K0.05%+$87.6K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q3 2026 | TickerTrail